Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Scleroderma
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 75 years
Gender
Both males and females

Description

Patients: All participants with ILD will be recruited from a Cerrahpasa Medical Faculty Hospital between January 2017 and June 2018. All treatments will performed in the same hospital. Sample Size: "Power and Sample Size Program" was used to calculate sample size. Power analysis was done with Pass 1...

Patients: All participants with ILD will be recruited from a Cerrahpasa Medical Faculty Hospital between January 2017 and June 2018. All treatments will performed in the same hospital. Sample Size: "Power and Sample Size Program" was used to calculate sample size. Power analysis was done with Pass 11 Home program. In the power analysis program, ? = 0,05, ? = 0,15 1- ? = 0,84. When the number of samples of the groups was 30 and 30, 84% power was obtained. Using a two-sided two-sample t-test, the standard deviations from the 0,05 alpha value are 7.0 and 6.0. Procedure: A list of individuals diagnosed with interstitial lung disease who are following the outpatient clinic of the Department of Chest Diseases of the Istanbul University Cerrahpa?a Medical Faculty and who meet the inclusion criteria for the study will be created. The created patient list will be enumerated. Two groups will be formed from the numbered persons by the random number table method (n = 60). Groups will receive 30 participants in the treatment group, whose protocol numbers end in an even number, and 30 members in the control group, who finished with an odd number of protocol numbers. Up to 10% of the sample size will be selected as a substitute, taking into account the non-participation of the selected individuals in the study. Assessments at baseline and after training will be performed by pulmonary physiotherapist. All the participants will be treated in the Cerrahpa?a Medical Faculty hospital by a physiotherapist who is experienced in pulmonary rehabilitation.

Tracking Information

NCT #
NCT03560154
Collaborators
Not Provided
Investigators
Study Director: Zerrin Yi?it, Prof Istanbul University/Institute of Cardiology